10. Network effect estimates and ranking statistics for periventricular leukomalacia (any grade).

Ibuprofen Mean SUCRA, 0.43; median rank, 2 (95% CrI, 1‐3)
1.30 ( 0.46, 4.16)	Indomethacin Mean SUCRA, 0.80; median rank, 1 (95% CrI, 1‐3)
0.94 ( 0.40, 2.02)	0.74 ( 0.30, 1.35)	Placebo Mean SUCRA, 0.28; median rank, 2 (95% CrI, 1‐3)

The unlabeled data in the boxes are risk ratios (RRs) and 95% credible intervals (CrIs). A RR >1 suggests that the upper left treatment is associated with a higher risk of having the outcome of interest vs the corresponding lower right treatment and the opposite is true for an RR <1. SUCRA, surface under the cumulative ranking curve